Contact Us
INNOGLY INNOGLY INNOGLY INNOGLY
Navigation
  • About us
    • COST Action
    • Network members
    • Scientific Outputs
      • Scientific Publications
      • Abstracts from Events
  • News
  • Events
  • Working Groups
    • Development and Cancer
    • Autophagy
    • Immunity
    • GAGs
  • STSM
    • STSM information
    • STSM proposal
    • STSM evaluation
    • Awarded STSMs
  • ITC Grants
  • Training Schools

Logged out

Lost Password?

News

INNOGLY ITC Conference Grants Call for Grant Period 4
Inclusiveness Target Countries (ITC) Conference Grant is a COST-networking tool aimed to ...
Read More
Closing Meeting of the INNOGLY COST Action, May 2-3, 2023, Heraklion, Crete, Greece
The Closing Meeting of the INNOGLY COST Action will take ...
Read More
Chemical Reviews : Glycosciences Issue
The Chemical Reviews thematic issue is called “Glycosciences” to illustrate ...
Read More
Training School on Conjugation of glycans onto nanomaterials: opportunities in therapy and diagnosis
Training School Conjugation of glycans onto nanomaterials: opportunities in therapy and ...
Read More
Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More

Research Topic: Frontiers in Immunology

Urinary tract infections (UTIs) are among the most common bacterial infections in humans worldwide. From 1990 to 2017 incident and death rates were observed to have increased by 52 % and 149 %, respectively. UTIs may lead to pyelonephritis and sepsis, which can result in fatal outcomes. One of the unresolved problems with UTIs are recurrent infections and pathogen multidrug resistance.

Gram-negative bacteria such as E. coli and P. mirabilis are the dominant cultivable pathogenic bacteria of UTIs. Multiple bacterial virulence factors – such as adhesins, exo-enzymes, biofilm formation, and pro-inflammatory activities (endotoxins) – are involved in catheter colonization, ascending infection, inflammation, and renal stone formation often associated with UTIs.

Recent advances in whole genomes sequencing (WGS), transcriptomes, and metabolomics are paving the way to more complete pictures of the human urinary tract microbiome and its role in UTIs. However, UTIs still remain complex biological phenomena that involve an interplay between hosts, pathogens, and environmental factors. As a result, multidisciplinary approaches are needed to advance our knowledge in the field of UTIs and to develop impactful novel treatment options.

In this Research Topic we aim to capture the latest developments in the pathogenesis of UTIs, as well as the molecular basis for adhesion and biofilm formation in UTIs. We welcome submissions on, but not limited to, the following sub themes:

• Urinary tract and gut microbiome analysis and its role in UTI pathogenesis.
• Elucidation of clonal P. mirabilis and E. coli differentiation during the course of UTIs, a phenomenon correlated with multidrug resistance in UTIs.
• Studies on the transition of planktonic bacterial to sessile cells and mono- and poly-species bacterial biofilms formation in UTIs.
• The molecular basis for adhesion and biofilm formation in UTIs.
• Novel nano- and biomaterials for catheter assembly with anti-bacterial features, for UTI prevention.

 

Keywords: Urinary Tract Infection, UTIs, Catheters, Biofilms, Bacterial Pathogenesis

 

Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

 

https://www.frontiersin.org/research-topics/20575/urinary-tract-infections-molecular-mechanisms-of-pathogenesis

March 25, 2021

Events

Closing Meeting of the INNOGLY COST Action, May 2-3, 2023, Heraklion, Crete, Greece
The Closing Meeting of the INNOGLY COST Action will take ...
Read More
Training School on Conjugation of glycans onto nanomaterials: opportunities in therapy and diagnosis
Training School Conjugation of glycans onto nanomaterials: opportunities in therapy and ...
Read More
Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More

Follow us on Twitter


Follow INNOGLY

Twitter Timeline

RT @RobertPdeVries1: New paper alert, many thanks to my friends from the island to drag us into this.
#PLOSPathogens: Phenotypic effects of…

RT @dunckerUAEM: https://t.co/UEPEzBxYYc

RT @glycoworld: It is a huge honor to be invited to present at the upcoming @EUROCARB21. I look forward to this fascinating event, and to r…

RT @EUROCARB21: Many of you requested it: we are pleased to announce an exceptional extension for the submission of your abstracts for Oral…

RT @GordanLauc: Dr Parastoo Azadi @CCRCUGA – Detailed N and O-glycan analysis by MSn analysis. Plenary lecture at the 3rd Meeting of the…

POLICY STATEMENT:

Biomedicine and Molecular Biosciences Action CA18103 is funded by COST, which is supported by the EU Framework Programme Horizon 2020.

COST Action CA18103

© Copyright 2023. All Rights Reserved | Powered by innogly.eu | Designed by AWA
  • Imprint
  • /
  • Privacy policy
  • /